Skip to main content
HR 6184 117th Congress House Crime and Law Enforcement Administrative law and regulatory procedures Department of Justice Drug trafficking and controlled substances Licensing and registrations Research administration and funding

HALT Fentanyl Act

Introduced: December 8, 2021 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Dec 9, 2021
Referred to the Subcommittee on Health.
Dec 8, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 8, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
What's happening now November 1, 2022

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Related & companion bills 3
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 93
R
Harshbarger, Diana
Tennessee · Nov 3, 2022
R
Finstad, Brad
Minnesota · Oct 18, 2022
R
Huizenga, Bill
Michigan · Sep 30, 2022
Carl, Jerry
· Sep 29, 2022
R
Obernolte, Jay
California · Sep 29, 2022
R
Donalds, Byron
Florida · Jul 12, 2022
R
Womack, Steve
Arkansas · May 18, 2022
Jacobs, Chris
· Mar 30, 2022
R
McCaul, Michael T.
Texas · Mar 30, 2022
R
Bice, Stephanie I.
Oklahoma · Mar 17, 2022
Cawthorn, Madison
· Mar 17, 2022
Gallagher, Mike
· Mar 17, 2022
Good, Bob
· Mar 17, 2022
R
Owens, Burgess
Utah · Mar 17, 2022
R
Timmons, William R.
South Carolina · Mar 9, 2022
LaTurner, Jake
· Mar 8, 2022
R
Letlow, Julia
Louisiana · Mar 8, 2022
R
Reschenthaler, Guy
Pennsylvania · Mar 8, 2022
R
Ellzey, Jake
Texas · Mar 7, 2022
R
Lucas, Frank D.
Oklahoma · Mar 7, 2022
Graves, Garret
· Mar 2, 2022
Mooney, Alexander
· Mar 2, 2022
R
Newhouse, Dan
Washington · Mar 2, 2022
R
Norman, Ralph
South Carolina · Mar 2, 2022
R
Palmer, Gary J.
Alabama · Mar 2, 2022
R
Stauber, Pete
Minnesota · Feb 18, 2022
R
Westerman, Bruce
Arkansas · Feb 18, 2022
R
Burchett, Tim
Tennessee · Feb 15, 2022
R
Fleischmann, Charles J. "Chuck"
Tennessee · Feb 15, 2022
R
Franklin, Scott
Florida · Feb 15, 2022
R
Grothman, Glenn
Wisconsin · Feb 15, 2022
Johnson, Bill
· Feb 15, 2022
R
Malliotakis, Nicole
New York · Feb 15, 2022
R
Moolenaar, John R.
Michigan · Feb 15, 2022
R
Williams, Roger
Texas · Feb 15, 2022
R
Cammack, Kat
Florida · Feb 8, 2022
Duncan, Jeff
· Feb 8, 2022
Walorski, Jackie
· Feb 8, 2022
R
Barr, Andy
Kentucky · Feb 7, 2022
R
Bost, Mike
Illinois · Feb 7, 2022
R
Issa, Darrell
California · Feb 7, 2022
R
Meuser, Daniel
Pennsylvania · Feb 7, 2022
R
Kelly, Mike
Pennsylvania · Feb 2, 2022
R
Steil, Bryan
Wisconsin · Feb 2, 2022
Bishop, Dan
· Feb 1, 2022
R
Pfluger, August
Texas · Feb 1, 2022
R
Calvert, Ken
California · Jan 19, 2022
Garcia, Mike
· Jan 19, 2022
R
Carter, John R.
Texas · Jan 14, 2022
Pence, Greg
· Jan 13, 2022
Page 1 of 2 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6184: HALT Fentanyl Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6184/
MLA
"H.R. 6184: HALT Fentanyl Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6184/.
Bluebook (legal)
H.R. 6184, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6184/.
Markdown link
[H.R. 6184: HALT Fentanyl Act](https://openamerica.io/bill/117-HR-6184/)
Report a problem